Judge Awards $181M In Fees To Firm That Got Arkansas $1.2B Risperdal Verdict

LITTLE ROCK, Ark. - An Arkansas state court judge on Jan. 31 ordered Johnson & Johnson to pay $181.1 million to a law firm that last year got the state government a record $1.2 billion verdict for alleged violations of state law in the marketing of the atypical antipsychotic drug Risperdal (State of Arkansas, ex rel. v. Ortho-McNeil-Janssen Pharmaceuticals, Inc., et al., No. CV 2007-14345, Ark. Cir., Pulaski Co.). Full story on lexis.com